IDEAYA Biosciences, Inc. (IDYA)
NASDAQ: IDYA · Real-Time Price · USD
34.03
+0.47 (1.40%)
At close: Dec 12, 2025, 4:00 PM EST
35.00
+0.97 (2.85%)
After-hours: Dec 12, 2025, 6:15 PM EST
IDEAYA Biosciences Market Cap
IDEAYA Biosciences has a market cap or net worth of $2.98 billion as of December 12, 2025. Its market cap has increased by 30.05% in one year.
Market Cap
2.98B
Enterprise Value
1.87B
1-Year Change
30.05%
Ranking
Category
Stock Price
$34.03
Market Cap Chart
Since May 23, 2019, IDEAYA Biosciences's market cap has increased from $215.57M to $2.98B, an increase of 1,283.93%. That is a compound annual growth rate of 49.27%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 11, 2025 | 2.94B | 32.45% |
| Dec 31, 2024 | 2.22B | -3.15% |
| Dec 29, 2023 | 2.29B | 162.34% |
| Dec 30, 2022 | 874.22M | -3.92% |
| Dec 31, 2021 | 909.90M | 123.69% |
| Dec 31, 2020 | 406.77M | 168.50% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| May 23, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 920.02B |
| Johnson & Johnson | 509.76B |
| AbbVie | 394.69B |
| UnitedHealth Group | 309.65B |
| AstraZeneca | 278.45B |
| Novartis AG | 254.39B |
| Merck & Co. | 248.95B |
| Novo Nordisk | 224.22B |